Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
Orphanet Journal of Rare Diseases
Published in:

Open Access 01-12-2024 | Research

Quality of life and caregiving burden associated with parenting a person with Duchenne/Becker muscular dystrophy in Poland

Authors: Jan Domaradzki, Dariusz Walkowiak

Published in: Orphanet Journal of Rare Diseases | Issue 1/2024

Login to get access

Abstract

Background

Duchenne and Becker muscular dystrophies (DBMD) are rare progressive, X-linked diseases of muscle wasting characterised by the early onset and prognosis of premature death. The aim of this study was to evaluate the impact of providing care for a person with DBMD on caregivers’ quality of life, perceived burden and financial well-being.

Results

202 Polish caregivers of a person with DBMD were included and completed a self-administered, computer-assisted online survey. Results show that DBMD affects the quality of life of caregivers who score significantly lower than the national average in every domain: 85.1% of DBMD caregivers scored below the national average in the physical health domain; in the environmental domain 83.7%; in the social relationships domain 82.2%; and in the psychological domain 72.3%. It also demonstrates that DBMD is a source of severe burden (mean score of 35.3). Finally, we report that while some dimensions of respondents’ quality of life and perceived burden were associated with patients’ age and caregivers’ educational status, financial well-being was the most important predictor of respondents’ quality of life and caregiving burden.

Conclusions

To improve DBMD caregivers’ quality of life and alleviate their burden, future intervention programs should promote resiliency and active coping and develop a social support system and respite care. Additionally, it is crucial to provide caregivers with adequate financial resources to fulfil their needs.
Literature
1.
Boettcher J, Boettcher M, Wiegand-Grefe S, Zapf H. Being the Pillar for Children with Rare Diseases-A Systematic Review on parental quality of life. Int J Environ Res Public Health. 2021;18:4993.PubMedPubMedCentralCrossRef
2.
Chung CCY, Ng NYT, Ng YNC, Lui ACY, Fung JLF, Chan MCY, et al. Socio-economic costs of rare diseases and the risk of financial hardship: a cross-sectional study. Lancet Reg Health West Pac. 2023;34:100711.PubMedPubMedCentral
3.
Magliano L, Patalano M, Sagliocchi A, Scutifero M, Zaccaro A, D’Angelo MG, et al. I have got something positive out of this situation: psychological benefits of caregiving in relatives of young people with muscular dystrophy. J Neurol. 2014;261:188–95.PubMedCrossRef
4.
Mcmullan J, Lohfeld L, McKnight AJ. Needs of informal caregivers of people with a rare disease: a rapid review of the literature. BMJ Open. 2022;12:e063263.PubMedPubMedCentralCrossRef
5.
Rihm L, Dreier M, Rezvani F, Wiegand-Grefe S, Dirmaier J. The psychosocial situation of families caring for children with rare diseases during the COVID-19 pandemic: results of a cross-sectional online survey. Orphanet J Rare Dis. 2022;17:449.PubMedPubMedCentralCrossRef
6.
Sandilands K, Williams A, Rylands AJ. Carer burden in rare inherited diseases: a literature review and conceptual model. Orphanet J Rare Dis. 2022;17:428.PubMedPubMedCentralCrossRef
7.
von der Lippe C, Neteland I, Feragen KB. Children with a rare congenital genetic disorder: a systematic review of parent experiences. Orphanet J Rare Dis. 2022;17:375.PubMedPubMedCentralCrossRef
8.
Yang L, Shu X, Mao S, Wang Y, Du X, Zou C. Genotype-phenotype correlations in Angelman Syndrome. Genes (Basel). 2021;12:987.PubMedCrossRef
9.
Belzer LT, Wright SM, Goodwin EJ, Singh MN, Carter BS. Psychosocial considerations for the child with Rare Disease: a review with recommendations and calls to action. Child (Basel). 2022;9:933.
10.
Witt S, Kristensen K, Wiegand-Grefe S, Boettcher J, Bloemeke J, Wingartz C, et al. Rare pediatric diseases and pathways to psychosocial care: a qualitative interview study with professional experts working with affected families in Germany. Orphanet J Rare Dis. 2021;16:497.PubMedPubMedCentralCrossRef
11.
12.
Fratantoni K, Livingston J, Schellinger SE, Aoun SM, Lyon ME. Family-centered Advance Care Planning: what matters most for parents of children with Rare diseases. Children. 2022;9:445.PubMedPubMedCentralCrossRef
13.
Boettcher J, Filter B, Denecke J, Hot A, Daubmann A, Zapf A, et al. Evaluation of two family-based intervention programs for children affected by rare disease and their families – research network (CARE-FAM-NET): study protocol for a rater-blinded, randomized, controlled, multicenter trial in a 2x2 factorial design. BMC Fam Pract. 2020;21:239.PubMedPubMedCentralCrossRef
14.
Domaradzki J, Walkowiak D. Invisible patients in rare diseases: parental experiences with the healthcare and social services for children with rare diseases. A mixed method study. Sci Rep. 2024;14:14016.PubMedPubMedCentralCrossRef
15.
Boyer F, Drame M, Morrone I, Novella J-L. Factors relating to carer burden for families of persons with muscular dystrophy. J Rehabil Med. 2006;38:309–15.PubMedCrossRef
16.
Flores D, Ribate MP, Montolio M, Ramos FJ, Gómez M, García CB. Quantifying the economic impact of caregiving for Duchenne muscular dystrophy (DMD) in Spain. Eur J Health Econ. 2020;21:1015–23.PubMedCrossRef
17.
Ishizaki M, Kobayashi M, Hashimoto H, Nakamura A, Maeda Y, Ueyama H, et al. Caregiver Burden with Duchenne and Becker muscular dystrophy in Japan: A Clinical Observation Study. Intern Med. 2024;63:365–72.PubMedCrossRef
18.
Kenneson A, Bobo JK. The effect of caregiving on women in families with Duchenne/Becker muscular dystrophy. Health Soc Care Community. 2010;18:520–8.PubMedCrossRef
19.
Peay HL, Meiser B, Kinnett K, Furlong P, Porter K, Tibben A. Mothers’ psychological adaptation to Duchenne/Becker muscular dystrophy. Eur J Hum Genet. 2016;24:633–7.PubMedCrossRef
20.
Peay HL, Meiser B, Kinnett K, Tibben A. Psychosocial needs and Facilitators of Mothers Caring for Children with Duchenne/Becker Muscular Dystrophy. J Genet Couns. 2018;27:197–203.PubMedCrossRef
21.
Schreiber-Katz O, Klug C, Thiele S, Schorling E, Zowe J, Reilich P, et al. Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany. Orphanet J Rare Dis. 2014;9:210.PubMedPubMedCentralCrossRef
22.
Abbott D, Carpenter J, Bushby K. Transition to adulthood for young men with Duchenne muscular dystrophy: research from the UK. Neuromuscul Disord. 2012;22:445–6.PubMedCrossRef
23.
Donaldson A, Guntrum D, Ciafaloni E, Statland J. Transition to Adulthood in Duchenne/Becker muscular dystrophy (P5.4-016). Neurology. 2019;92(15supplement):P54–016.
24.
Wasilewska E, Małgorzewicz S, Sobierajska-Rek A, Jabłońska-Brudło J, Górska L, Śledzińska K, et al. Transition from Childhood to Adulthood in patients with Duchenne muscular dystrophy. Med (Kaunas). 2020;56:426.
25.
Colvin MK, Poysky J, Kinnett K, Damiani M, Gibbons M, Hoskin J, et al. Psychosocial Management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142(Suppl 2):S99–109.PubMedCrossRef
26.
Kinnett K, Rodger S, Vroom E, Furlong P, Aartsma-Rus A, Bushby K. Imperatives for DUCHENNE MD: a simplified guide to Comprehensive Care for Duchenne muscular dystrophy. PLoS Curr. 2015;7. ecurrents.md.87770501e86f36f1c71e0a5882ed9ba1.
27.
Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021;7:1–19.CrossRef
28.
29.
Crisafulli S, Sultana J, Fontana A, Salvo F, Messina S, Trifirò G. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet J Rare Dis. 2020;15:141.PubMedPubMedCentralCrossRef
30.
Salari N, Fatahi B, Valipour E, Kazeminia M, Fatahian R, Kiaei A, et al. Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis. J Orthop Surg Res. 2022;17:96.PubMedPubMedCentralCrossRef
31.
32.
Darmahkasih AJ, Rybalsky I, Tian C, Shellenbarger KC, Horn PS, Lambert JT, et al. Neurodevelopmental, behavioral, and emotional symptoms common in Duchenne muscular dystrophy. Muscle Nerve. 2020;61:466–74.PubMedCrossRef
33.
Poysky P J. Behavior patterns in Duchenne muscular dystrophy: report on the parent project muscular dystrophy behavior workshop 8–9 of December 2006, Philadelphia, USA. Neuromuscul Disord. 2007;17:986–94.PubMedCrossRef
34.
Ricotti V, Mandy WPL, Scoto M, Pane M, Deconinck N, Messina S, et al. Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations. Dev Med Child Neurol. 2016;58:77–84.PubMedCrossRef
35.
36.
Wahlgren L, Kroksmark A-K, Lindblad A, Tulinius M, Sofou K. Respiratory comorbidities and treatments in Duchenne muscular dystrophy: impact on life expectancy and causes of death. J Neurol. 2024;271:4300–9.PubMedPubMedCentralCrossRef
37.
Holloway SM, Wilcox DE, Wilcox A, Dean JCS, Berg JN, Goudie DR, et al. Life expectancy and death from cardiomyopathy amongst carriers of Duchenne and Becker muscular dystrophy in Scotland. Heart. 2008;94:633–6.PubMedCrossRef
38.
de Moura MCDS, Wutzki HC, Voos MC, Resende MBD, Reed UC, Hasue RH. Is functional dependence of Duchenne muscular dystrophy patients determinant of the quality of life and burden of their caregivers? Arq Neuropsiquiatr. 2015;73:52–7.PubMedCrossRef
39.
Landfeldt E, Edström J, Buccella F, Kirschner J, Lochmüller H. Duchenne muscular dystrophy and caregiver burden: a systematic review. Dev Med Child Neurol. 2018;60:987–96.PubMedCrossRef
40.
Magliano L, D’Angelo MG, Vita G, Pane M, D’Amico A, Balottin U, et al. Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study. Acta Myol. 2014;33:136–43.PubMedPubMedCentral
41.
Abi Daoud MS, Dooley JM, Gordon KE. Depression in parents of children with Duchenne muscular dystrophy. Pediatr Neurol. 2004;31:16–9.PubMedCrossRef
42.
Landfeldt E, Lindgren P, Bell CF, Guglieri M, Straub V, Lochmüller H, et al. Quantifying the burden of caregiving in Duchenne muscular dystrophy. J Neurol. 2016;263:906–15.PubMedPubMedCentralCrossRef
43.
Nozoe KT, Kim LJ, Polesel DN, Hirotsu C, de Souza AL, Hachul H, et al. Sleep pattern and spectral analysis of caregiver-mothers of sons with Duchenne muscular dystrophy, and an examination of differences between carriers and non-carriers. Sleep Med. 2017;32:114–21.PubMedCrossRef
44.
Thompson RJ, Zeman JL, Fanurik D, Sirotkin-Roses M. The role of parent stress and coping and family functioning in parent and child adjustment to Duchenne muscular dystrophy. J Clin Psychol. 1992;48:11–9.PubMedCrossRef
45.
James CA, Hadley DW, Holtzman NA, Winkelstein JA. How does the mode of inheritance of a genetic condition influence families? A study of guilt, blame, stigma, and understanding of inheritance and reproductive risks in families with X-linked and autosomal recessive diseases. Genet Med. 2006;8:234–42.PubMedCrossRef
46.
Thomas PT, Rajaram P, Nalini A. Psychosocial challenges in family caregiving with children suffering from Duchenne muscular dystrophy. Health Soc Work. 2014;39:144–52.PubMedCrossRef
47.
Chen J-Y, Chen S-S, Jong Y-J, Yang Y-H, Chang Y-Y. A comparison of the stress and coping strategies between the parents of children with Duchenne muscular dystrophy and children with a fever. J Pediatr Nurs. 2002;17:369–79.PubMedCrossRef
48.
Goldman A, Metcalfe A, MacLeod R. The process of Disclosure: mothers’ experiences of communicating X-Linked carrier risk information to At-Risk daughters. J Genet Couns. 2018;27:1265–74.PubMedPubMedCentralCrossRef
49.
Nozoe KT, Hachul H, Hirotsu C, Polesel DN, Moreira GA, Tufik S, et al. The relationship between sexual function and quality of sleep in caregiving mothers of sons with duchenne muscular dystrophy. Sex Med. 2014;2:133–40.PubMedPubMedCentralCrossRef
50.
Soelaeman RH, Smith MG, Sahay K, Tilford JM, Goodenough D, Paramsothy P, et al. Labor market participation and productivity costs for female caregivers of minor male children with Duchenne and Becker muscular dystrophies. Muscle Nerve. 2021;64:717–25.PubMedPubMedCentralCrossRef
51.
Teoh LJ, Geelhoed EA, Bayley K, Leonard H, Laing NG. Health care utilization and costs for children and adults with duchenne muscular dystrophy. Muscle Nerve. 2016;53:877–84.PubMedCrossRef
52.
53.
Schwartz CE, Stark RB, Audhya IF, Gooch KL. Characterizing the quality-of-life impact of Duchenne muscular dystrophy on caregivers: a case-control investigation. J Patient-Reported Outcomes. 2021;5.
54.
Anikiej P, Mański A, Bidzan M. Aktualizacja-siebie rodziców dzieci z dystrofią mięśniową Duchenne’a. Niepełnosprawność - zagadnienia Problemy rozwiązania. 2018;2(27):37–53.
55.
Borczykowska-Rzepka M. Poczucie Satysfakcji i sensu życia u matek dzieci z dystrofią mięśniową duchenne’a – rozważaniateoretyczno-empiryczne. Państwo i Społeczeństwo. 2020;1:65–86.
56.
Sawicka-Gutaj N, Gruszczyński D, Guzik P, Mostowska A, Walkowiak J. Publication ethics of human studies in the light of the declaration of Helsinki – a mini-review. J Med Sci. 2022;91:e700–700.CrossRef
57.
Jaracz K, Kalfoss M, Górna K, Baczyk G. Quality of life in Polish respondents: psychometric properties of the Polish WHOQOL-Bref. Scand J Caring Sci. 2006;20:251–60.PubMedCrossRef
58.
Szatkowska K, Basińska MA. Burden in family caregivers: the psychometric properties of Polish version of the Zarit Burden Interview. Psychiatr Pol. 2024;58:51–62.PubMedCrossRef
59.
60.
Pangalila RF, Van Den Bos GAM, Stam HJ, Van Exel NJA, Brouwer WBF, Roebroeck ME. Subjective caregiver burden of parents of adults with Duchenne muscular dystrophy. Disabil Rehabil. 2012;34:988–96.PubMedCrossRef
61.
Cavazza M, Kodra Y, Armeni P, De Santis M, López-Bastida J, Linertová R, et al. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe. Eur J Health Econ. 2016;17:19–29.PubMedCrossRef
62.
Ciafaloni E, Fox DJ, Pandya S, Westfield CP, Puzhankara S, Romitti PA, et al. Delayed diagnosis in Duchenne muscular dystrophy: data from the muscular dystrophy surveillance, Tracking, and Research Network (MD STARnet). J Pediatr. 2009;155:380–5.PubMedPubMedCentralCrossRef
63.
Thomas S, Conway KM, Fapo O, Street N, Mathews KD, Mann JR, Network, et al. Muscle Nerve. 2022;66:2000–15.CrossRef
64.
Crossnohere NL, Armstrong N, Fischer R, Bridges JFP. Diagnostic experiences of Duchenne families and their preferences for newborn screening: A mixed-methods study. American Journal of Medical Genetics Part C, Seminars in Medical Genetics. 2022;190:169.
65.
Wong SH, McClaren BJ, Archibald AD, Weeks A, Langmaid T, Ryan MM, et al. A mixed methods study of age at diagnosis and diagnostic odyssey for Duchenne muscular dystrophy. Eur J Hum Genet. 2015;23:1294–300.PubMedPubMedCentralCrossRef
66.
Bhattacharyya O, Campoamor NB, Armstrong N, Freed M, Schrader R, Crossnohere NL, et al. Assessing the benefits and Harms Associated with early diagnosis from the perspective of parents with multiple children diagnosed with Duchenne muscular dystrophy. Int J Neonatal Screen. 2024;10:32.PubMedPubMedCentralCrossRef
67.
Ryder S, Leadley RM, Armstrong N, Westwood M, de Kock S, Butt T, et al. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet J Rare Dis. 2017;12:79.PubMedPubMedCentralCrossRef
68.
Landfeldt E, Lindgren P, Bell CF, Schmitt C, Guglieri M, Straub V, et al. The burden of Duchenne muscular dystrophy: an international, cross-sectional study. Neurology. 2014;83:529–36.PubMedPubMedCentralCrossRef
69.
Schwartz CE, Stark RB, Borowiec K, Audhya IF, Gooch KL. Interplay of disability, caregiver impact, and out-of-pocket expenditures in Duchenne muscular dystrophy: a cohort study. J Patient-Reported Outcomes. 2022;6:21.CrossRef
70.
Yamaguchi M, Sonoda E, Suzuki M. The experience of parents of adult sons with Duchenne muscular dystrophy regarding their prolonged roles as primary caregivers: a serial qualitative study. Disabil Rehabil. 2019;41:746–52.PubMedCrossRef
71.
Rodríguez AA, Amayra I, López-Paz JF, Martínez O, García M, Salgueiro M, et al. The role of associations in reducing the emotional and financial impact on parents caring for children with Duchenne muscular dystrophy: a cross-cultural study. Int J Environ Res Public Health. 2022;19:12334.PubMedPubMedCentralCrossRef
72.
Labisa P, Andreozzi V, Mota M, Monteiro S, Alves R, Almeida J, et al. Cost of illness in patients with Duchenne muscular dystrophy in Portugal: the COIDUCH Study. PharmacoEconomics Open. 2022;6:211–8.PubMedCrossRef
Metadata
Title
Quality of life and caregiving burden associated with parenting a person with Duchenne/Becker muscular dystrophy in Poland
Authors
Jan Domaradzki
Dariusz Walkowiak
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2024
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-024-03481-7

Other articles of this Issue 1/2024

Different diseases, different needs: Patient preferences for gene therapy in lysosomal storage disorders, a probabilistic threshold technique survey

Treatment guidelines for rare, early-onset conditions associated with epileptic seizures: a literature review on Rett syndrome and tuberous sclerosis complex

A scoping review of health literacy in rare disorders: key issues and research directions

NR1H4 disease: rapidly progressing neonatal intrahepatic cholestasis and early death

Clinical symptoms, biochemistry, and liver histology during the native liver period of progressive familial intrahepatic cholestasis type 2

Infrared spectroscopy as a new approach for early fabry disease screening: a pilot study